Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

redsoxwin20042004 3 posts  |  Last Activity: Sep 29, 2015 11:32 AM Member since: Mar 31, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Help with Opinion

    by arrosto Sep 25, 2015 1:10 PM
    redsoxwin20042004 redsoxwin20042004 Sep 29, 2015 11:32 AM Flag

    IMO it's because no one really knows who Pulmatrix is as a company. Most stock owners are not the general public. Likewise, people don't understand the value of an inhaled anti-fungal however, they need look no further than Acorda (ACOR) Therapeutics who is being very successful thru their inhaled version of an old (generic) Parkinson's drug. I would buy PULM and not look at it again for 18-24months...if their clinical trial goes well, you're a hero...if not, well you just have to get out.

  • Reply to

    PATENT LAWS

    by gladpick Sep 23, 2015 4:02 PM
    redsoxwin20042004 redsoxwin20042004 Sep 24, 2015 8:09 AM Flag

    My understanding is that Concert was able to procure the IP for a deuterated version of Kalydeco years ago it is unclear if Concert can do this again for Orkambi or other CF related compounds. I think Vertex has improved their IP protection from deuterium-modified versions of their compounds. Worth mentioning is that CEO @ Concert Pharma was instrumental in the success of Kalydeco for Vertex years ago.

  • Reply to

    Orkambi Side Effects

    by longlivevrtx Sep 22, 2015 4:55 PM
    redsoxwin20042004 redsoxwin20042004 Sep 23, 2015 1:47 PM Flag

    Our DD has been on Orkambi for 75 days, the only initial side affects were some chest tightening and a few days of increased mucus production. This is the longest she's gone without antibiotics in 3 years.

VRTX
97.09+0.71(+0.74%)Aug 26 4:00 PMEDT